Search clinical trials for: SKI-606 (Bosutinib)
Total 4347 results
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHealthyUnited States
-
Massachusetts General HospitalPfizer; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
PfizerCompletedBreast Neoplasms | Neoplasm MetastasisUnited States, Ukraine, Russian Federation, Hong Kong, France, Australia, Poland, Malta
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); PfizerTerminatedChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blasts Under 15 Percent of Bone Marrow Nucleated Cells | Blasts Under 15 Percent of Peripheral Blood White Cells | Blasts Under 30 Percent of Bone Marrow Nucleated Cells | Blasts Under 30 Percent of Peripheral Blood White CellsUnited States
-
PfizerCompletedPhiladelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML)Singapore
-
Georgetown UniversityAlzheimer's AssociationCompletedDementia With Lewy BodiesUnited States
-
PfizerCompletedChronic Myeloid LeukemiaUnited States, Spain, Australia, Canada, Hong Kong, Singapore, United Kingdom, Germany, Netherlands, Chile, India, South Africa, Sweden, Peru, Argentina, Italy, Austria, Colombia, Brazil, China, Finland, Hungary, Korea, Republic of, M... and more
-
PfizerCompletedChronic Myelogenous LeukemiaJapan
-
University of Milano BicoccaIRCCS San RaffaeleCompletedLeukemia | BCR-ABL Positive | Myelogenous | ChronicItaly
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedLeukemia | Breast Cancer | TumorsNetherlands
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAccelerated Phase Chronic Myelogenous Leukemia (CML) | Blast Phase Chronic Myelogenous Leukemia (CML) | Chronic Phase Phase Chronic Myelogenous Leukemia (CML) | Philadelphia Chromosome Positive (Ph+) Phase Chronic Myelogenous Leukemia (CML)United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | B Acute Lymphoblastic Leukemia With t(9;22)(q34... and other conditionsUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHealthy SubjectsUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
PfizerWyeth is now a wholly owned subsidiary of PfizerCompletedChronic Myeloid LeukemiaFrance, United States, Spain, Belgium, Singapore, Poland, Canada, Japan, United Kingdom, Taiwan, Hungary, Germany, Argentina, Russian Federation, Turkey, Colombia, Italy, South Africa, Brazil, Chile, China, Hong Kong, India, Korea, Republic... and more
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHealthy SubjectsUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Neurological Associates of West Los AngelesPfizerEnrolling by invitationDementia | Mild Cognitive ImpairmentUnited States
-
PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
PfizerCompletedHealthy ParticipantsNetherlands
-
Kyoto UniversityPfizer; Kitasato University; Tokushima University; Tottori UniversityRecruiting
-
PfizerCompleted
-
Children's Oncology GroupPfizer; Erasmus Medical Center; Dutch Childhood Oncology Group; Innovative Therapies...Active, not recruitingAccelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Blastic Phase Chronic Myelogenous Leukemia | Philadelphia Chromosome Positive CMLUnited States
-
PfizerCompletedRenal Insufficiency, Chronic | Renal Insufficiency, Acute | Renal Disease, End-StageUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
PfizerCompletedMyeloid LeukemiaUnited Kingdom
-
PfizerCompleted
-
PfizerCompletedChronic Myeloid LeukemiaUnited States, Canada, Spain, China, Australia, Singapore, Korea, Republic of, France, Hong Kong, Netherlands, Turkey, Poland, Japan, United Kingdom, Argentina, Colombia, Hungary, Russian Federation, South Africa, Belgium, Brazil, Chil... and more
-
PfizerCompletedLeukemia, Chronic MyelogenousJapan
-
PfizerpH AssociatesCompletedChronic Myeloid LeukaemiaUnited Kingdom
-
PfizerCompletedPolycystic Kidney, Autosomal DominantUnited States, Canada, Australia, Sweden, Spain, Poland, Korea, Republic of, Switzerland, United Kingdom, Moldova, Republic of, Italy, Czech Republic, Hungary, Lithuania, Romania, Slovakia, Turkey
-
PETHEMA FoundationCompleted
-
Scarless Laboratories, Inc.Recruiting
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedBreast Cancer | Leukemia, Myeloid, ChronicPoland
-
Scarless Laboratories, Inc.ethica Clinical Research Inc.Completed
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruiting
-
University of BonnPfizer; RWTH Aachen University; Ludwig-Maximilians - University of Munich; Heidelberg... and other collaboratorsUnknownChronic Myelogenous LeukaemiaGermany
-
PfizerDevelopmental Therapeutics ConsortiumTerminatedPreviously Treated PH + CMLSpain, United States, Austria, Sweden, Germany, France, Italy, Norway
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
University College, LondonDermatrustWithdrawn
-
Orlucent, IncUnknownNevus | Dysplasia; EpithelialUnited States
-
Beijing Pearl Biotechnology Limited Liability CompanyCompleted
-
Beijing Pearl Biotechnology Limited Liability CompanyCompletedNon-Small Cell Lung CancerChina